Evidence map›Paper›PMID 28902865›Full record

ArticlePloS one2017

Optimization of the expression, purification and polymerase activity reaction conditions of recombinant human PrimPol.

Elizaveta O Boldinova, Gorazd Stojkovič, Rafil Khairullin, Sjoerd Wanrooij, Alena V Makarova

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Strand Displacement Activity of PrimPol.International journal of molecular sciences · 2020
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Elizaveta O BoldinovaInstitute of Molecular Genetics of Russian Academy of Sciences, Kurchatov sq. 2, Moscow, Russia.
Gorazd StojkovičDepartment of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
Rafil KhairullinDepartment of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
Sjoerd WanrooijDepartment of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
Alena V MakarovaInstitute of Molecular Genetics of Russian Academy of Sciences, Kurchatov sq. 2, Moscow, Russia.ORCID http://orcid.org/0000-0002-6513-892X
Russian Academy of Sciences · RUUmeå University · SEKazan Federal University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human PrimPol is a DNA primase/polymerase involved in DNA damage tolerance and prevents nuclear genome instability. PrimPol is also localized to the mitochondria, but its precise function in mitochondrial DNA maintenance has remained elusive. PrimPol works both as a translesion (TLS) polymerase and as the primase that restarts DNA replication after a lesion. However, the observed biochemical activities of PrimPol vary considerably between studies as a result of different reaction conditions used. To reveal the effects of reaction composition on PrimPol DNA polymerase activity, we tested the polymerase activity in the presence of various buffer agents, salt concentrations, pH values and metal cofactors. Additionally, the enzyme stability was analyzed under various conditions. We demonstrate that the reaction buffer with pH 6-6.5, low salt concentrations and 3 mM Mg2+ or 0.3-3 mM Mn2+ cofactor ions supports the highest DNA polymerase activity of human PrimPol in vitro. The DNA polymerase activity of PrimPol was found to be stable after multiple freeze-thaw cycles and prolonged protein incubation on ice. However, rapid heat-inactivation of the enzyme was observed at 37ºC. We also for the first time describe the purification of human PrimPol from a human cell line and compare the benefits of this approach to the expression in Escherichia coli and in Saccharomyces cerevisiae cells. Our results show that active PrimPol can be purified from E. coli and human suspension cell line in high quantities and that the activity of the purified enzyme is similar in both expression systems. Conversely, the yield of full-length protein expressed in S. cerevisiae was considerably lower and this system is therefore not recommended for expression of full-length recombinant human PrimPol.

Indexed as

CalibrationCells, CulturedDNA-Directed DNA PolymeraseDNA PrimaseEscherichia coliGene Expression Regulation, BacterialHEK293 CellsHumansMetabolic EngineeringMultifunctional EnzymesOrganisms, Genetically ModifiedPolymerase Chain ReactionProtein StabilityRecombinant ProteinsDNA-Directed DNA PolymeraseDNA PrimaseMultifunctional EnzymesPrimPol protein, humanRecombinant Proteins

Identifiers

PMID28902865
PMCPMC5597260
OpenAlexW2755243452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.